Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Omzo review
Cost a year out and the banner stops helping. A first month of $199 plus eleven at $299 is $3,488 for semaglutide; the "$179" on the front page never appears on a bill. Tirzepatide is $349 then $399, so $4,738. The prices are real and itemized — they are just in the Terms and Conditions rather than on a pricing page, and the tirzepatide figure the homepage advertises is not in that schedule at all.
then $299/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Omzo at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- All 50 states
- Start
- Days after the telehealth consultation
How we scored Omzo
Each factor is read off Omzo's published pricing, disclosures and intake flow, and the six roll up into the 49/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Tiered or opaque — the true monthly is hard to pin down up front.
Broad coverage, but not a confirmed all-50 footprint.
Not a two-molecule plan on the published facts — switching may mean starting again elsewhere.
Exit terms are the weak point: lock-in, notice periods, or a cancellation path that isn't published.
The hardest start to fit around a workday — a scheduled visit, or no published answer either way.
The weakest showing on speed — a slow published timeline, or none at all.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- omzo.com
Checked on 18 August 2026, with the figures taken from the Terms and Conditions, the only surface carrying a schedule. Compounded semaglutide is $299 a month after $199 for the first; tirzepatide $399 after $349. Costed out, that is $3,488 for a first year of semaglutide and $4,738 for tirzepatide. Brand-name Ozempic and Zepbound are $1,299 and $1,399 a month, first month and after, each covering consultation, prescription, medication and shipping. Three things about the advertising. The homepage's "starting at $179" is 40% below the ongoing rate. The Terms describe $179 as the original price and $199 as the current one, which is an increase written as a markdown. And "$279", the homepage's tirzepatide figure, appears nowhere in the schedule. In its favor, the same document is more explicit about compounding than most: compounded drugs are not FDA-approved, the agency does not review them for safety or quality, and no equivalence to an approved drug is claimed. It serves all 50 states, carries a LegitScript seal, names no operating company or compounding pharmacy, and screened clean against the live FDA warning-letter index.
What to expect when you sign up
We walked Omzo's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on omzo.com (https://www.omzo.com/quiz-v2)
- 2The signup page opened normally when we checked it on 2026-08-21
- 3We stopped at the first signup screen and entered no personal details, so we can't tell you what comes after it
What we noticed
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideFollow-up months — the standing rateThe Terms publish "Follow-Up Consultation - GLP-1 ... Priced at $299", with the first month at $199. The homepage advertises "Starting at $179" — a figure the Terms describe as the ORIGINAL price, now superseded by a higher one. | $199 → $299 | Follow-up months — the standing rateThe Terms publish "Follow-Up Consultation - GLP-1 ... Priced at $299", with the first month at $199. The homepage advertises "Starting at $179" — a figure the Terms describe as the ORIGINAL price, now superseded by a higher one. |
| Compounded tirzepatideFollow-up months — the standing rate"Follow-Up Consultation - GLP-1 + GIP ... Priced at $399", first month $349. The homepage's "Starting at $279" appears nowhere in the schedule at all. | $349 → $399 | Follow-up months — the standing rate"Follow-Up Consultation - GLP-1 + GIP ... Priced at $399", first month $349. The homepage's "Starting at $279" appears nowhere in the schedule at all. |
| Brand semaglutideOzempic — every month"Priced at $1,299" for both the initial and the follow-up package, described as covering consultation, prescription, medication and shipping. | $1299 | Ozempic — every month"Priced at $1,299" for both the initial and the follow-up package, described as covering consultation, prescription, medication and shipping. |
| Brand tirzepatideZepbound — every month"Priced at $1,399", initial and follow-up alike. | $1399 | Zepbound — every month"Priced at $1,399", initial and follow-up alike. |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Omzo's public disclosures at last review and change often; confirm the current number on Omzo's own site.
What we like
- Six packages, each with a first-month and an ongoing price, all published
- Consultation, prescription, medication, shipping and ongoing support are named as included in each
- Explicit about compounding: not FDA-approved, not reviewed for safety or quality, no equivalence claimed
- Brand-name Ozempic and Zepbound are priced, at $1,299 and $1,399 a month
- All 50 states, and it says it ships nowhere outside them
- LegitScript certified
The caveats
- The advertised $179 is 40% below the $299 that applies from month two
- "Originally priced at $179, currently offered at $199" is an increase written as a markdown
- $279, the homepage's tirzepatide figure, is not in the schedule in any position
- The schedule lives in a legal page that nothing on the site links to
- No operating company named anywhere in the legal pages
- No compounding pharmacy named
Omzo for working moms: our verdict
Cost a year out and the banner stops helping. A first month of $199 plus eleven at $299 is $3,488 for semaglutide; the "$179" on the front page never appears on a bill. Tirzepatide is $349 then $399, so $4,738. The prices are real and itemized — they are just in the Terms and Conditions rather than on a pricing page, and the tirzepatide figure the homepage advertises is not in that schedule at all. The advertised entry is $199, but the standing rate settles near $299/month — so read the headline as a starting offer, not the monthly line on your budget.
We weigh Omzo the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What Omzo will cost you
- Compounded semaglutide — Follow-up months — the standing rate: $199 to start, then $299/mo
- Compounded tirzepatide — Follow-up months — the standing rate: $349 to start, then $399/mo
- Brand-name semaglutide — Ozempic — every month: $1299/mo
- Brand-name tirzepatide — Zepbound — every month: $1399/mo
For context, the typical ongoing price across our roster is around $179/month, so Omzo sits at the premium end.
The medications Omzo prescribes
Omzo prescribes semaglutide and tirzepatide — the two best-evidenced molecules in the class, and having both on one account matters because you can switch between them without re-enrolling or hunting down a new provider mid-plan. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own labeling, though the brand price runs well above the compounded tiers.
Where Omzo fits — and where it doesn't — for working moms
Right for you if…
- nationwide access matters — a move for work or family shouldn't interrupt care.
Not your best option if…
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence in Omzo's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Omzo is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: A mother budgeting twelve months who wants a published schedule, even if she has to open a legal page to find it.
Alternatives to Omzo
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing Omzo
Head-to-head & alternatives
Omzo, answered
- How much does Omzo cost?
- Budget around $299 a month — that was Omzo's lowest ongoing compounded rate at last review ($299/mo semaglutide, $399/mo tirzepatide). Verify the all-in figure on their site before you plan around it; these numbers change often.
- Can I start Omzo without a scheduled video visit?
- Omzo involves more clinician touchpoints (and, in some cases, a scheduled visit), so it isn't the fastest async start. If a no-video signup is your priority, our #1 pick is built for it.
- Does Omzo offer both semaglutide and tirzepatide?
- Yes — Omzo offers both molecules, so you can switch without re-enrolling. Tirzepatide's dual GIP/GLP-1 action posts the strongest published weight-loss numbers.
- Where does Omzo rank for working moms?
- Omzo earns 49/100 on our Rx-Readiness Score, ranking #243. Speed to first dose and flat pricing carry the most weight of the six factors behind it. CoreAge Rx leads — see how they compare.
Pricing, states and verification reflect Omzo's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.